Logo image of EMX.CA

EMX ROYALTY CORP (EMX.CA) Stock Fundamental Analysis

TSX-V:EMX - TSX Venture Exchange - CA26873J1075 - Common Stock - Currency: CAD

3.33  -0.01 (-0.3%)

Fundamental Rating

4

Overall EMX gets a fundamental rating of 4 out of 10. We evaluated EMX against 807 industry peers in the Metals & Mining industry. EMX has only an average score on both its financial health and profitability. EMX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year EMX has reported negative net income.
EMX had a positive operating cash flow in the past year.
In the past 5 years EMX reported 4 times negative net income.
In multiple years EMX reported negative operating cash flow during the last 5 years.
EMX.CA Yearly Net Income VS EBIT VS OCF VS FCFEMX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.13%, EMX belongs to the top of the industry, outperforming 84.51% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.17%, EMX belongs to the top of the industry, outperforming 85.13% of the companies in the same industry.
With an excellent Return On Invested Capital value of 1.40%, EMX belongs to the best of the industry, outperforming 88.72% of the companies in the same industry.
Industry RankSector Rank
ROA 0.13%
ROE 0.17%
ROIC 1.4%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
EMX.CA Yearly ROA, ROE, ROICEMX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

EMX has a better Profit Margin (0.67%) than 89.47% of its industry peers.
EMX has a Operating Margin of 9.93%. This is amongst the best in the industry. EMX outperforms 89.59% of its industry peers.
Industry RankSector Rank
OM 9.93%
PM (TTM) 0.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX.CA Yearly Profit, Operating, Gross MarginsEMX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMX is destroying value.
EMX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EMX has been increased compared to 5 years ago.
EMX has a worse debt/assets ratio than last year.
EMX.CA Yearly Shares OutstandingEMX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EMX.CA Yearly Total Debt VS Total AssetsEMX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 5.43 indicates that EMX is not in any danger for bankruptcy at the moment.
EMX has a better Altman-Z score (5.43) than 68.28% of its industry peers.
EMX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, EMX is doing worse than 68.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 5.43
ROIC/WACC0.18
WACC7.84%
EMX.CA Yearly LT Debt VS Equity VS FCFEMX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

EMX has a Current Ratio of 8.56. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.56, EMX belongs to the best of the industry, outperforming 83.77% of the companies in the same industry.
A Quick Ratio of 8.56 indicates that EMX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 8.56, EMX belongs to the top of the industry, outperforming 83.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.56
Quick Ratio 8.56
EMX.CA Yearly Current Assets VS Current LiabilitesEMX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

EMX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.75%, which is quite impressive.
EMX shows a decrease in Revenue. In the last year, the revenue decreased by -1.62%.
EMX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.11% yearly.
EPS 1Y (TTM)107.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.08%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%34.97%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 63.03% on average per year.
Based on estimates for the next years, EMX will show a small growth in Revenue. The Revenue will grow by 6.70% on average per year.
EPS Next Y200%
EPS Next 2Y82.57%
EPS Next 3Y63.03%
EPS Next 5YN/A
Revenue Next Year-7.81%
Revenue Next 2Y1.93%
Revenue Next 3Y6.7%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EMX.CA Yearly Revenue VS EstimatesEMX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EMX.CA Yearly EPS VS EstimatesEMX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Forward Earnings ratio of 80.83, the valuation of EMX can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EMX indicates a rather cheap valuation: EMX is cheaper than 85.63% of the companies listed in the same industry.
EMX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 80.83
EMX.CA Price Earnings VS Forward Price EarningsEMX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EMX is valued cheaper than 88.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.71
EMX.CA Per share dataEMX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

EMX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EMX's earnings are expected to grow with 63.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.57%
EPS Next 3Y63.03%

0

5. Dividend

5.1 Amount

EMX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EMX ROYALTY CORP

TSX-V:EMX (6/13/2025, 7:00:00 PM)

3.33

-0.01 (-0.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-11 2025-05-11/amc
Earnings (Next)08-11 2025-08-11
Inst Owners17.57%
Inst Owner ChangeN/A
Ins Owners14.98%
Ins Owner ChangeN/A
Market Cap359.71M
Analysts84.44
Price Target4.85 (45.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.56%
PT rev (3m)11.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 80.83
P/S 12.14
P/FCF N/A
P/OCF 50.81
P/B 3.12
P/tB 3.12
EV/EBITDA 38.71
EPS(TTM)0
EYN/A
EPS(NY)0.04
Fwd EY1.24%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.07
OCFY1.97%
SpS0.27
BVpS1.07
TBVpS1.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.17%
ROCE 1.94%
ROIC 1.4%
ROICexc 1.69%
ROICexgc 1.69%
OM 9.93%
PM (TTM) 0.67%
GM N/A
FCFM N/A
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.69
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.09
Cash Conversion 75.55%
Profit Quality N/A
Current Ratio 8.56
Quick Ratio 8.56
Altman-Z 5.43
F-Score6
WACC7.84%
ROIC/WACC0.18
Cap/Depr(3y)25.77%
Cap/Depr(5y)19.56%
Cap/Sales(3y)6.62%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.08%
EPS Next Y200%
EPS Next 2Y82.57%
EPS Next 3Y63.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%34.97%
Revenue Next Year-7.81%
Revenue Next 2Y1.93%
Revenue Next 3Y6.7%
Revenue Next 5YN/A
EBIT growth 1Y-31.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2186.51%
EBIT Next 3Y205.17%
EBIT Next 5YN/A
FCF growth 1Y44.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y220.22%
OCF growth 3YN/A
OCF growth 5YN/A